These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38469347)

  • 21. Analyses of Short-Term Antagonistic Evolution of Pseudomonas aeruginosa Strain PAO1 and Phage KPP22 (Myoviridae Family, PB1-Like Virus Genus).
    Uchiyama J; Suzuki M; Nishifuji K; Kato SI; Miyata R; Nasukawa T; Yamaguchi K; Takemura-Uchiyama I; Ujihara T; Shimakura H; Murakami H; Okamoto N; Sakaguchi Y; Shibayama K; Sakaguchi M; Matsuzaki S
    Appl Environ Microbiol; 2016 Aug; 82(15):4482-4491. PubMed ID: 27208109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriophages of Pseudomonas aeruginosa: long-term prospects for use in phage therapy.
    Krylov VN
    Adv Virus Res; 2014; 88():227-78. PubMed ID: 24373314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled bacteriophage therapy in a porcine model of pneumonia caused by Pseudomonas aeruginosa during mechanical ventilation.
    Guillon A; Pardessus J; L'Hostis G; Fevre C; Barc C; Dalloneau E; Jouan Y; Bodier-Montagutelli E; Perez Y; Thorey C; Mereghetti L; Cabrera M; Riou M; Vecellio L; Le Guellec S; Heuzé-Vourc'h N
    Br J Pharmacol; 2021 Sep; 178(18):3829-3842. PubMed ID: 33974271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
    Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effect and anti-biofilm ability assessment of a novel phage, phiPA1-3, against carbapenem-resistant Pseudomonas aeruginosa.
    Tsai YC; Lee YP; Lin NT; Yang HH; Teh SH; Lin LC
    Virus Res; 2023 Oct; 335():199178. PubMed ID: 37490958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of Bacteriophages in Removing Biofilms of
    Fong SA; Drilling A; Morales S; Cornet ME; Woodworth BA; Fokkens WJ; Psaltis AJ; Vreugde S; Wormald PJ
    Front Cell Infect Microbiol; 2017; 7():418. PubMed ID: 29018773
    [No Abstract]   [Full Text] [Related]  

  • 27. Improving the Inhibitory Effect of Phages against
    Aghaee BL; Khan Mirzaei M; Alikhani MY; Mojtahedi A; Maurice CF
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel N4-Like Bacteriophage Isolated from a Wastewater Source in South India with Activity against Several Multidrug-Resistant Clinical Pseudomonas aeruginosa Isolates.
    Menon ND; Kumar MS; Satheesh Babu TG; Bose S; Vijayakumar G; Baswe M; Chatterjee M; D'Silva JR; Shetty K; Haripriyan J; Kumar A; Nair S; Somanath P; Nair BG; Nizet V; Kumar GB
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance against two lytic phage variants attenuates virulence and antibiotic resistance in
    García-Cruz JC; Rebollar-Juarez X; Limones-Martinez A; Santos-Lopez CS; Toya S; Maeda T; Ceapă CD; Blasco L; Tomás M; Díaz-Velásquez CE; Vaca-Paniagua F; Díaz-Guerrero M; Cazares D; Cazares A; Hernández-Durán M; López-Jácome LE; Franco-Cendejas R; Husain FM; Khan A; Arshad M; Morales-Espinosa R; Fernández-Presas AM; Cadet F; Wood TK; García-Contreras R
    Front Cell Infect Microbiol; 2023; 13():1280265. PubMed ID: 38298921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance Evolution against Phage Combinations Depends on the Timing and Order of Exposure.
    Wright RCT; Friman VP; Smith MCM; Brockhurst MA
    mBio; 2019 Sep; 10(5):. PubMed ID: 31551330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Innate Immune Susceptibility in Hyperpigmented Bacteriophage-Resistant Mutants of Pseudomonas aeruginosa.
    Menon ND; Penziner S; Montaño ET; Zurich R; Pride DT; Nair BG; Kumar GB; Nizet V
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0023922. PubMed ID: 35862755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phage Morons Play an Important Role in Pseudomonas aeruginosa Phenotypes.
    Tsao YF; Taylor VL; Kala S; Bondy-Denomy J; Khan AN; Bona D; Cattoir V; Lory S; Davidson AR; Maxwell KL
    J Bacteriol; 2018 Nov; 200(22):. PubMed ID: 30150232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models.
    Tiwari BR; Kim S; Rahman M; Kim J
    J Microbiol; 2011 Dec; 49(6):994-9. PubMed ID: 22203564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phages, Fitness, Virulence, and Synergy: A Novel Approach for the Therapy of Infections Caused by Pseudomonas aeruginosa.
    Stratton CW
    J Infect Dis; 2017 Mar; 215(5):668-670. PubMed ID: 28007923
    [No Abstract]   [Full Text] [Related]  

  • 35. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
    AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Complement Inhibits Myophages against
    Egido JE; Dekker SO; Toner-Bartelds C; Lood C; Rooijakkers SHM; Bardoel BW; Haas PJ
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections.
    Danis-Wlodarczyk K; Vandenheuvel D; Jang HB; Briers Y; Olszak T; Arabski M; Wasik S; Drabik M; Higgins G; Tyrrell J; Harvey BJ; Noben JP; Lavigne R; Drulis-Kawa Z
    Sci Rep; 2016 Jun; 6():28115. PubMed ID: 27301427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designing P. aeruginosa synthetic phages with reduced genomes.
    Pires DP; Monteiro R; Mil-Homens D; Fialho A; Lu TK; Azeredo J
    Sci Rep; 2021 Jan; 11(1):2164. PubMed ID: 33495501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Directed in Vitro Evolution of Therapeutic Bacteriophages: The Appelmans Protocol.
    Burrowes BH; Molineux IJ; Fralick JA
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30862096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Concerted Action of Two B3-Like Prophage Genes Excludes Superinfecting Bacteriophages by Blocking DNA Entry into Pseudomonas aeruginosa.
    Carballo-Ontiveros MA; Cazares A; Vinuesa P; Kameyama L; Guarneros G
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32461312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.